Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Severe combined immunodeficiency with sensitivity to ionizing radiation


Other Names for this Disease
  • RS-SCID
  • SCID, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, with sensitivity to ionizing radiation
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

News & Events


ORDR Co-Sponsored Conferences

  • 2016 Rare Disease Day at NIH, Monday, February 29, 2016
    Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
    Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.

  • Primary Immune Deficiency Treatment Consortium Annual Scientific Meeting, Thursday, April 09, 2015
    Location: Houston, TX
    Description: The Specific Aim of this Workshop is to create a scientific forum for junior and senior investigators with a special interest in PID to focus on timely topics with respect to the immunobiology, diagnosis and therapeutic correction of PIDs leading to hypothesis-based prospective clinical trials that will optimize the care and durable correction of disease in children with PID.

  • Primary Immune Deficiency Treatment Consortium (PIDTC) Scientific Workshop, Thursday, May 01, 2014 - Saturday, May 03, 2014
    Location: Seattle, WA
    Description: The first three PIDTC Annual Scientific Workshops beginning in 2011 focused on critical topics for patients with SCID, Wiskott-Aldrich Syndrome (WAS) and Chronic Granulomatous Disease (CGD). Over 2012 and 2013, the Workshop has seen participation increase by more than 25% with a significant portion consisting of trainees and junior faculty interested in PID. We have also seen increasing participation from European colleagues resulting in the recent commitment to collaborate on PIDTC’s natural history study in CGD. Further discussion with European colleagues is underway to collaborate on PIDTC’s study of outcomes for patients with SCID who received HCT and have survived 25 years or more. Finally, the Workshops have facilitated the development of the first ever prospective multicenter intervention trial for newborns with SCID.

  • Primary Immune Deficiency Treatment Consortium (PIDTC) Scientific Workshop, Thursday, April 07, 2011 - Saturday, April 09, 2011
    Location: San Francisco, CA
    Description: This was a 3-day meeting. Participation at the workshop was by invitation and included representatives from each of the centers participating at PIDTC as well as representatives of CIBMTR, USIDNET, NIAID, ORDR, EBMT, and ESID. This was meant to favor collaboration and promote international collaborative trials in the field of these rare disorders. Special attention was paid to invitation of young investigators at a senior stage in their training or at the beginning of their academic careers. The meeting was open to representatives of the patient advocacy groups that are active in the field of primary immune deficiencies (PIDs) with the intent of promoting communication and collaboration. The results of the meeting will be published in a peer-reviewed journal.

  • Primary Immunodeficiency Disease Consortium Conference, Thursday, June 11, 2009
    Location: San Francisco, CA
    Description: The CIS Primary Immune Deficiency Consortium Conference provided new investigators in this field the continued opportunity to enhance career development by learning from leaders in the field of primary immunodeficiency and other young investigators from institutions across the Americas and Europe.

Other Names for this Disease
  • RS-SCID
  • SCID, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, with sensitivity to ionizing radiation
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.